134 related articles for article (PubMed ID: 11754386)
1. Lack of enhancing effect of two Kampo medicines, Sho-saiko-to (TJ-9) and Sairei-to (TJ-114), on rat urinary bladder carcinogenesis initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Sano M; Tanaka H; Kawabe M; Tamano S; Kadota T; Yanagisawa T; Maemura S; Ito N; Shirai T
Teratog Carcinog Mutagen; 2002; 22(1):41-50. PubMed ID: 11754386
[TBL] [Abstract][Full Text] [Related]
2. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
3. Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shibata MA; Nakanishi K; Shibata M; Masui T; Miyata Y; Ito N
Urol Res; 1986; 14(4):201-6. PubMed ID: 3787885
[TBL] [Abstract][Full Text] [Related]
4. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Lina BA; Woutersen RA
Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
8. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
[TBL] [Abstract][Full Text] [Related]
9. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
[TBL] [Abstract][Full Text] [Related]
10. Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Hagiwara A; Fukushima S; Kitaori M; Shibata M; Ito N
Gan; 1984 Sep; 75(9):763-8. PubMed ID: 6500232
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
[TBL] [Abstract][Full Text] [Related]
12. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
[TBL] [Abstract][Full Text] [Related]
13. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
14. Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
Hirose M; Fukushima S; Sakata T; Inui M; Ito N
Cancer Lett; 1983 Nov; 21(1):23-7. PubMed ID: 6640511
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
Inoue T; Imaida K; Suzuki E; Okada M; Fukushima S
Cancer Lett; 1988 Jun; 40(3):265-73. PubMed ID: 3383181
[TBL] [Abstract][Full Text] [Related]
16. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
Hirose M; Yamaguchi T; Kimoto N; Ogawa K; Futakuchi M; Sano M; Shirai T
Int J Cancer; 1998 Aug; 77(5):773-7. PubMed ID: 9688312
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
[TBL] [Abstract][Full Text] [Related]
18. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
19. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
[TBL] [Abstract][Full Text] [Related]
20. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
